Dermatology clinical trials recruiting in California

78 recruiting dermatology trials match in California. Showing 20.

• The Effects of Audio-Based Therapy on Anxiety in PsoriasisRecruiting

  N/A · University of California, San Francisco · San Francisco, California

• A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)Recruiting

  Phase 1 · UCB Biopharma SRL · Santa Monica, California

• A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe EczemaRecruiting

  Phase 3 · Pfizer · St. Petersburg, Florida

• A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)Recruiting

  Phase 4 · Eli Lilly and Company · Fountain Valley, California

• A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque PsoriasisRecruiting

  Phase 3 · Takeda · Chula Vista, California

• A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe EczemaRecruiting

  Phase 3 · Pfizer · Huntington Beach, California

• Psoriatic Immune Response to TildrakizumabRecruiting

  Phase 4 · University of California, San Francisco · San Francisco, California

• A Study of LY4005130 in Adult Participants With Non-Segmental VitiligoRecruiting

  Phase 2 · Eli Lilly and Company · Fremont, California

• Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild AcneRecruiting

  Phase 1 / Phase 2 · Sanofi Pasteur, a Sanofi Company · Encino, California

• A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic DermatitisRecruiting

  Phase 3 · Nektar Therapeutics · Oxnard, California

• A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic DermatitisRecruiting

  Phase 3 · AbbVie · Palo Alto, California

• A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With VitiligoRecruiting

  Phase 1 · Teva Branded Pharmaceutical Products R&D LLC · Fremont, California

• A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque PsoriasisRecruiting

  Phase 2 · InventisBio Co., Ltd · Chula Vista, California

• An Open-Label Extension Study of ORKA-001 in Participants With Plaque PsoriasisRecruiting

  Phase 2 · Oruka Therapeutics, Inc. · Fountain Valley, California

• A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic DermatitisRecruiting

  Phase 2 · Hoffmann-La Roche · Minneapolis, Minnesota

• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar PustulosisRecruiting

  Phase 3 · UCB Biopharma SRL · Fremont, California

• Study to Assess Safety, Pharmacokinetics, and Treatment Effect of CabtreoRecruiting

  Phase 4 · Bausch Health Americas, Inc. · Freemont, California

• A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic DermatitisRecruiting

  Phase 2 · Apollo Therapeutics Ltd · Huntington Beach, California

• Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.Recruiting

  Phase 4 · Integrative Skin Science and Research · Sacramento, California

• Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)Recruiting

  Phase 2 · Merck Sharp & Dohme LLC · Riverside, California

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.